Oruka Therapeutics (ORKA) Capital Expenditures (QoQ) (2011 - 2026)
Powered by 
Analysis
Oruka Therapeutics (ORKA) Capital Expenditures (QoQ) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn |
| 10 | Oruka Therapeutics | 5.89 Bn | 4.16 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 15.87% |
| Dec 31, 2025 | -26.74% |
| Mar 31, 2025 | 233.33% |
| Dec 31, 2024 | -85.94% |
| Mar 31, 2022 | -71.43% |
| Dec 31, 2021 | -50.00% |
| Sep 30, 2021 | -12.50% |
| Jun 30, 2021 | 166.67% |
| Mar 31, 2021 | -14.29% |
| Dec 31, 2020 | 16.67% |
| Sep 30, 2020 | 100.00% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 50.00% |
| Mar 31, 2018 | 0.00% |
| Jun 30, 2016 | 4,128.57% |
| Mar 31, 2016 | 138.89% |
| Dec 31, 2015 | -460.00% |
| Sep 30, 2015 | -97.75% |
| Jun 30, 2015 | 11,000.00% |
| Mar 31, 2015 | -97.85% |